Table 2 Stem cells products approved for clinic pre-clinic trial by the SFDA
From: Regenerative medicine in China: main progress in different fields
Accept No. | Generic name | Usage | Date | Unit | Status |
|---|---|---|---|---|---|
X0400586 | Bone marrow mesenchymal stem cells | Injection | 2004.02 | The foundation of the Chinese academy of sciences institute of medicine | Approved |
CSL20020071 | Human recombinant stem cell factor for injection | Injection | 2003.05 | The Second Military Medical University | Approved |
X0408234 | Mesenchymal stem cells in myocardial infarction for injection | Injection | 2005.01 | Beijing Yuanhefa Biotechnology | Approved |
X0407487 | Autologous bone marrow mesenchymal stem cells for injection | Injection | 2004.12 | Institute of transfusion medicine, Academy of Military Medical Science of PLA | Approved |
CSL01037 | Recombinant stem cell factor for injection | Injection | 2001.09 | Institute of transfusion medicine, Academy of Military Medical Science of PLA | Approved |
X0404120 | Umbilical cord blood nuclear progenitor cell for injection | Injection | 2004.07 | Institute of transfusion medicine, Academy of Military Medical Science of PLA | Approved |
X0404119 | Umbilical cord blood red blood cell precursors for injection | Injection | 2004.08 | Institute of transfusion medicine, Academy of Military Medical Science of PLA | Approved |